SCHOTT Pharma AG & Co KgaA (1SXP)

Currency in EUR
24.40
-0.20(-0.81%)
Closed·

SCHOTT Pharma (1SXP) Stock Forecast & Price Target

Advanced Equity Forecast
Overall Consensus
Buy
8 Buy
2 Hold
2 Sell
Data based on a poll of the past 3 months

Analysts 12-Month Price Target

Average 29.79
(+22.10% Upside)

Past 24 Months

12-Month Forecast

Analyst Ratings

Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Deutsche Bank
Buy31.00+27.05%34.00MaintainJul 25, 2025
Barclays
Buy30.00+22.95%32.00MaintainJul 16, 2025
UBS
Buy29.20+19.67%28.20MaintainMay 20, 2025
Barclays
Buy32.00+31.15%26.00UpgradeMay 20, 2025
Citi
Buy35.00+43.44%37.00MaintainApr 17, 2025

Fair Value

Average
Upside
Uncertainty
Spread
Market Range
52 weeks
€19
€37
Analyst Targets
12 analysts
€23
€36
Fair Value
14 models

FAQ

Is 1SXP a Buy, Sell, or Hold?

The consensus rating for SCHOTT Pharma is "Buy", based on insights from 12 analysts. 8 analysts recommend buying the stock, 2 suggest selling, and 2 recommend holding.

What Is the Price Target for SCHOTT Pharma (1SXP) According to Analysts?

According to projections from 12 analysts, the average 12-month price target for SCHOTT Pharma is 29.79167, with a high estimate of 36 and a low estimate of 23.

What Is 1SXP’s Potential Upside or Downside, Based on the Analysts’ Average Price Target?

SCHOTT Pharma has a potential Upside of +22.10%, based on analysts’ average price target.

How Has SCHOTT Pharma Stock Performed Over the Past 52 Weeks?

The SCHOTT Pharma 52-week range spans from 18.50 to 36.88.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.